BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI) Stock Price, Quote, News & History

Key Statistics

Open

$1.17

Volume / Avg.

0 / 27.99K

Day Range

- - -

52 Wk Range

0.46 - 1.69

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Brainstorm Cell Therapeutics Inc News

Brainstorm Cell Therapeutics Crashes 42% After Voluntary Nasdaq Delisting Announcement

BrainStorm Cell Therapeutics Inc. shares crashed 42.74% to $0.67 in after-hours trading on Friday after the company announced its voluntary delisting from the Nasdaq Capital Market.

Mohd Haider

Partner Content

Presenting Encouraging Data, Acquiring Licenses, Issuing Patents And More – BioRestorative's Inroads Bringing Its Stem Cell Therapies To Market

Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

Avi Kapoor

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Avi Kapoor

Partner Content

BioRestorative Therapies Presents Promising Data At Orthopaedic Research Society (ORS) 2024 Annual Meeting

BioRestorative Therapies (NASDAQ: BRTX) is a clinical-stage biotech company that is developing cell-based therapies to treat chronic lumbar disc disease and metabolic conditions such as obesity and diabetes.

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-4.06M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

3.24M

Free Cash Flow (TTM)

-4.06M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-816.00K

Valuation Metrics

Enterprise Value

$14.59M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

-73.33%

Earnings Yield % (FWD)

-75.83%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$1.05

Company Debt

Total Debt

$1.26M

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$22.00K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$1.17

Volume / Avg.

0 / 27.99K

Day Range

- - -

52 Wk Range

0.46 - 1.69

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Brainstorm Cell Therapeutics Inc is a biotechnology company committed to the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis, progressive mult...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

BCLI

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

BCLI

FAQ

How do I buy BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI) stock?

You can purchase shares of BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (OTCQB:BCLI) through any online brokerage.

View our list of the best stock brokerages

Who are BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI) competitors?

There are no as such competitors for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc..

What is the forecast, or price target, for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI) stock?

There is no analysis for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. to provide a consensus price target.

What is the current price for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI)?

The stock price for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) is $1.2 last updated August 26, 2026 at 3:57 PM EDT.

Does BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI) pay a dividend?

There are no upcoming dividends for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc..

When is BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (OTCQB:BCLI) reporting earnings?

BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. does not have any upcoming earnings scheduled.

Is BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI) going to split?

There is no upcoming split for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc..

What sector and industry does BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI) operate in?

BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.